Skip to main content

2 Result(s)

within S Zohar Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit?

    Our purpose was to assess success rates in children of achieving optimal hematopoietic progenitor cells (HPCs) harvest after mobilization with 300 μg/kg pegfilgrastim. Between January 2005 and January 2007, 26...

    E Merlin, S Zohar, C Jérôme, R Veyrat-Masson, G Marceau… in Bone Marrow Transplantation (2009)

  2. No Access

    Article

    The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients

    A study was conducted to compare the efficiency and toxicity of two peripheral blood stem cell (PBSC) mobilization procedures for newly diagnosed patients with multiple myeloma. Patients from group 1 (n=51) were ...

    F Lefrère, S Zohar, D Ghez, R Delarue, F Audat, F Suarez… in Bone Marrow Transplantation (2006)